|
Variable
|
Total
|
Survivors
|
Non-survivors
|
P value
|
|---|
|
Patients
|
185 (100.0)
|
99 (53.5)
|
86 (46.5)
| |
|
Age, years
|
47 (18.2)
|
43 (17.4)
|
51 (18.3)
|
0.003
|
|
Men
|
128 (69.2)
|
74 (74.7)
|
54 (62.8)
|
0.079
|
|
APACHE II, score
|
16 (1–37)
|
12 (1–30)
|
21 (9–37)
|
<0.001
|
|
SOFA, score
|
6 (0–20)
|
5 (0–14)
|
9 (2–20)
|
<0.001
|
|
Predicted mortality, %
|
25 (4–85)
|
15 (4–75)
|
40 (9–85)
|
<0.001
|
|
Comorbidities
| | | | |
|
DM2
|
58 (31.4)
|
23 (23.2)
|
35 (40.7)
|
0.011
|
|
Ischemic cardiopathy
|
24 (13.0)
|
12 (12.1)
|
12 (14.0)
|
0.711
|
|
Chronic nephropathy
|
23 (12.4)
|
5 (5.1)
|
18 (20.9)
|
0.001
|
|
Chronic liver disease
|
7 (3.8)
|
2 (2.0)
|
5 (5.8)
|
0.265
|
|
Chronic pneumopathy
|
7 (3.8)
|
4 (4.0)
|
3 (3.5)
|
1.000
|
|
Blood neoplasia
|
1 (0.5)
|
1 (1.0)
|
0 (0.0)
|
1.000
|
|
Solid neoplasia
|
15 (8.1)
|
4 (4.4)
|
11 (12.8)
|
0.030
|
|
HIV infection
|
5 (2.7)
|
1 (1.0)
|
4 (4.7)
|
0.285
|
|
ICU admission diagnosis
| | | | |
|
Medical
|
87 (47.0)
|
37 (37.4)
|
50 (58.1)
|
0.005
|
|
Surgical, urgent
|
40 (21.6)
|
19 (19.2)
|
21 (24.4)
|
0.389
|
|
Surgical, elective
|
25 (13.5)
|
21 (21.2)
|
4 (4.7)
|
0.001
|
|
Trauma
|
33 (17.8)
|
22 (22.2)
|
11 (12.8)
|
0.095
|
|
ICU admission eosinophils count, K/μL
|
0.013 (0.0–0.578)
|
0.014 (0.0–0.363)
|
0.010 (0.0–0.578)
|
0.355
|
|
Hospital stay, days
|
14 (2–96)
|
18 (3–96)
|
11.5 (2–56)
|
0.007
|
|
ICU stay, days
|
6 (1–46)
|
5 (1–28)
|
7.5 (1–46)
|
0.004
|
- Data are shown as number and percentage, mean and standard deviation or median and interquartile range as needed
-
ICU intensive care unit, APACHE II acute physiology and chronic health evaluation II, SOFA sequential organ failure assessment score, DM2 type 2 diabetes mellitus, HIV human immunodeficiency virus
